Clariscan

Clariscan (Gadoteric Acid) is a contrast agent used in MRI scans to enhance image clarity. It is administered intravenously and is manufactured by GE Healthcare AS in the EU.

Clariscan is primarily used to improve the visibility of internal structures during magnetic resonance imaging (MRI). It helps in diagnosing various conditions by making abnormalities more apparent. The contrast agent is often used in MRI scans of the brain, spine, and other body parts to provide clearer images.

Clariscan works by temporarily altering the magnetic properties of tissues, which enhances the contrast in MRI images. This can help healthcare professionals identify and evaluate abnormalities more effectively. The effects are typically short-lived and localized to the area being scanned.

Clariscan should be used with caution in patients with kidney problems or a history of allergic reactions to contrast agents. It is important to inform your healthcare provider about any existing medical conditions or allergies before administration. Always follow the guidance of a healthcare professional.

Clariscan may interact with certain medications or medical conditions. It is important to disclose all current medications and health conditions to your healthcare provider. Specific interactions with alcohol or other substances have not been widely documented, but general precautions should be observed.